IP Library › Patent Application 18939064
Patent Application
App. No. 18/939,064

DYSREGULATION OF TRAUMA REGULATION PATHWAY TREATMENT AND MONITORING TECHNIQUES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/939,064
Abstract

The subject matter of the present disclosure generally relates to techniques for addressing or correcting dysregulation of the trauma regulation pathway. The dysregulation may be associated with a physiological condition, such as a SARS-CoV-2 viral infection. In an embodiment, the techniques include treating dysregulation based on a renin-angiotensin pathway molecule or cell and/or a splenic pathway molecule or cell using targeted neuromodulation. In an embodiment, neuromodulation is used to regulate the immune system, e.g., as an energy-based adjuvant for a vaccine.

Claims (6)

1 . A method of inducing an immunological response in a subject, comprising:

administering a vaccine to the subject; and

applying ultrasound energy to an internal tissue of the subject as an energy-based adjuvant for the vaccine.

2 . The method of claim 1 , wherein the ultrasound energy is applied on a same day as the vaccine is administered or at least a day after the vaccine is administered.

3 . The method of claim 1 , wherein the internal tissue is a lymph node.

4 . The method of claim 1 , wherein the vaccine is a SARS-CoV-2 vaccine.